BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18052620)

  • 1. Validation of high-performance liquid chromatography methods for determination of zidovudine, stavudine, lamivudine and indinavir in human plasma.
    Tarinas A; Tápanes RD; Ferrer G; Pérez J
    Farm Hosp; 2007; 31(4):243-7. PubMed ID: 18052620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of stavudine and lamivudine in human plasma by high performance liquid chromatography and its application to a bioavailability study.
    Wattananat T; Prasanchaimontri IO; Akarawut W
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):369-77. PubMed ID: 20578520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
    Verweij-van Wissen CP; Aarnoutse RE; Burger DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):121-9. PubMed ID: 15664342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
    Estrela Rde C; Salvadori MC; Suarez-Kurtz G
    Rapid Commun Mass Spectrom; 2004; 18(10):1147-55. PubMed ID: 15150840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
    Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
    J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC.
    Fan B; Stewart JT
    J Pharm Biomed Anal; 2002 Jun; 28(5):903-8. PubMed ID: 12039632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma.
    Mistri HN; Jangid AG; Pudage A; Gomes N; Sanyal M; Shrivastav P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):320-32. PubMed ID: 17481969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers.
    Nandi U; Das A; Roy B; Choudhury H; Gorain B; Pal TK
    Drug Test Anal; 2013 Jun; 5(6):485-91. PubMed ID: 22374835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of lamivudine, stavudine and nevirapine in human plasma by LC-MS/MS and its application to pharmacokinetic study in clinic.
    Li Z; Ding C; Ge Q; Zhou Z; Zhi X; Liu X
    Biomed Chromatogr; 2010 Sep; 24(9):926-34. PubMed ID: 20058328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch.
    Fan B; Bartlett MG; Stewart JT
    Biomed Chromatogr; 2002 Sep; 16(6):383-9. PubMed ID: 12228894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
    Kuritzkes DR; Bassett RL; Johnson VA; Marschner IC; Eron JJ; Sommadossi JP; Acosta EP; Murphy RL; Fife K; Wood K; Bell D; Martinez A; Pettinelli CB
    AIDS; 2000 Jul; 14(11):1553-61. PubMed ID: 10983642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry.
    Kenney KB; Wring SA; Carr RM; Wells GN; Dunn JA
    J Pharm Biomed Anal; 2000 Jul; 22(6):967-83. PubMed ID: 10857566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
    Squires KE; Gulick R; Tebas P; Santana J; Mulanovich V; Clark R; Yangco B; Marlowe SI; Wright D; Cohen C; Cooley T; Mauney J; Uffelman K; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1591-600. PubMed ID: 10983646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
    Foudraine NA; de Jong JJ; Jan Weverling G; van Benthem BH; Maas J; Keet IP; Jurriaans S; Roos MT; Vandermeulen K; de Wolf F; Lange JM
    AIDS; 1998 Aug; 12(12):1513-9. PubMed ID: 9727573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasma.
    Rower JE; Klein B; Bushman LR; Anderson PL
    Biomed Chromatogr; 2012 Jan; 26(1):12-20. PubMed ID: 21465499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA; Jurriaans S; Weverling GJ; Burger DM; Hoetelmans RM; Roos MT; Maas J; Miedema F; Reiss P; Portegies P; de Wolf F; Lange JM
    Antivir Ther; 2001 Mar; 6(1):55-62. PubMed ID: 11417762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study.
    Nirogi R; Kandikere V; Komarneni P; Aleti R; Padala N; Kalaikadhiban I; Bhyrapuneni G; Muddana N
    Biomed Chromatogr; 2012 Dec; 26(12):1472-81. PubMed ID: 22344535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of lamivudine, zidovudine, and nevirapine in capillary blood sampled on filter paper by LC.
    Malm M; Römsing S; Obua C; Bergqvist Y
    J Chromatogr Sci; 2009; 47(10):855-62. PubMed ID: 19930794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
    Foudraine NA; Hoetelmans RM; Lange JM; de Wolf F; van Benthem BH; Maas JJ; Keet IP; Portegies P
    Lancet; 1998 May; 351(9115):1547-51. PubMed ID: 10326538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.